Lungpacer presents at the 2022 Pleural Pressure Working Group (PLUG) meeting
The Pleural Pressure Working Group (PLUG) is an international network of physicians and investigators working on advanced monitoring of mechanical ventilation and respiratory failure. Our goal is to promote research and use of advanced monitoring, discuss study results, and provide educational tools. PLUG working group is open to anybody interested in this topic and is […]
Lungpacer presents at Society of Critical Care Medicine (SCCM) virtual conference
Lungpacer presents at 2022 International Symposium on Intensive Care and Emergency Medicine (ISICEM) conference in Brussels
Lungpacer wins the Jon DeHaan Foundation Innovation in Cardiology Award
“On behalf of myself and the Lungpacer medical team we would like to express our deep appreciation for being selected as the winner of the Jon DeHaan Foundation’s Award for Innovation in Cardiology at the 2021 TCT Conference. This recognition will further support the development of Lungpacer’s transvascular neurostimulation therapy, which is designed to empower […]
Lungpacer Medical Wins TCT 2021 Shark Tank Innovation Competition
Award recognizes medical device company pioneering a therapy to build diaphragm strength and empower natural, independent breathing for patients who require mechanical ventilation
First COVID-19 Patient in Germany successfully treated with novel Diaphragm Therapy
Greifswald University Hospital tests new method (Lungpacer® System) for weaning of respiratory patients Constanze Steinke Pressearbeit Universität Greifswald 07/10/2020 08:54 Department B for Internal Medicine of the University Medical Center Greifswald successfully used, within an international multi-center trial, a special diaphragmatic stimulation therapy to treat a COVID-19 patient as the first clinical site in Europe. […]
Lungpacer Medical, Inc. Announces FDA Approval of Emergency Use Authorization of the Lungpacer Diaphragm Pacing Therapy System to Help Address COVID-19 Pandemic
VANCOUVER, British Columbia, April 14, 2020 Lungpacer Medical, Inc., a medical device company developing an intravenous catheter-based phrenic-nerve-pacing system, announced today that the FDA has approved the Emergency Use Authorization for the use of the Lungpacer Diaphragm Pacing Therapy System (DPTS) to assist in weaning patients determined by their healthcare provider to be at high […]
Lungpacer Medical, Inc. Presentations at American Thoracic Society Conference, Scheduled for May 2020, Philadelphia, Pennsylvania
An average of 14,000 pulmonary, critical care and sleep medicine clinicians and researchers from around the world attend the ATS multidisciplinary conference each year. Unfortunately, due to the COVID-19 global crisis the 2020 meeting has been cancelled. However, Lungpacer Medical, Inc. is pleased to announce that four preclinical abstracts were accepted for poster presentation, and […]